IO-202
IO-202-CL-001
Phase 1 mab completed
Quick answer
IO-202 for AML With Monocytic Differentiation is a Phase 1 program (mab) at BeOne Medicines with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BeOne Medicines
- Indication
- AML With Monocytic Differentiation
- Phase
- Phase 1
- Modality
- mab
- Status
- completed